Securities Report - 22nd Period (2025/04/01 - 2026/03/31)

Kusuri no Madoguchi Co., Ltd. Securities Report - 22nd Period (2025/04/01 - 2026/03/31)

This document is the Securities Report filed by Kusuri no Madoguchi Co., Ltd. with the Tokyo Stock Exchange in accordance with the Financial Instruments and Exchange Act. It discloses the company's business performance, financial position, management policies, future outlook, and risk factors for the 22nd period (April 1, 2025 to March 31, 2026).

The company operates as an e-commerce business specializing in the online sale of pharmaceuticals and healthcare-related products, with a mission to provide customers with safe and convenient medical services. By offering prescription medication services and pharmacist-led medication guidance, it is advancing the integration of healthcare and digital technology.

This report aims to provide transparent information disclosure to a wide range of stakeholders, including investors, financial institutions, analysts, and media. It includes comprehensive information necessary for investment decisions, such as financial statements, accounting policies, and auditor opinions.

Going forward, the company will continue to strengthen corporate governance and transparent information disclosure to build trust with shareholders, investors, and all other stakeholders.